POLL: Women are More Likely to Develop Hidradenitis Suppurativa - True or False?

Poll

Click here to answer this week's poll.

True or False: Women are more likely to develop HS than men.

True
False
Related Videos
Related Content

Combination Surgery Plus Adalimumab More Clincially Effective in HS Than Adalimumab Alone

September 25th 2023

Combination Treatments in HS Require Further Review

September 22nd 2023

Hidradenitis Suppurativa May Lead to Skin Changes, Peripheral Neuropathy

September 21st 2023

Psychiatric Comorbidities Present in 1 in 4 Patients With HS

September 18th 2023

Izokibep Fails in Phase 2b/3 Hidradenitis Suppurativa Trial

September 12th 2023

Endo-Radiofrequency Deemed a Safe, Effective Modality for Axillary HS Treatment

August 31st 2023

Combination Surgery Plus Adalimumab More Clincially Effective in HS Than Adalimumab Alone

September 25th 2023

Combination Treatments in HS Require Further Review

September 22nd 2023

Hidradenitis Suppurativa May Lead to Skin Changes, Peripheral Neuropathy

September 21st 2023

Psychiatric Comorbidities Present in 1 in 4 Patients With HS

September 18th 2023

Izokibep Fails in Phase 2b/3 Hidradenitis Suppurativa Trial

September 12th 2023

Endo-Radiofrequency Deemed a Safe, Effective Modality for Axillary HS Treatment

August 31st 2023

Combination Surgery Plus Adalimumab More Clincially Effective in HS Than Adalimumab Alone

September 25th 2023

Combination Treatments in HS Require Further Review

September 22nd 2023

Hidradenitis Suppurativa May Lead to Skin Changes, Peripheral Neuropathy

September 21st 2023

Psychiatric Comorbidities Present in 1 in 4 Patients With HS

September 18th 2023

Izokibep Fails in Phase 2b/3 Hidradenitis Suppurativa Trial

September 12th 2023

Endo-Radiofrequency Deemed a Safe, Effective Modality for Axillary HS Treatment

August 31st 2023
© 2023 MJH Life Sciences

All rights reserved.